Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
CMP
vs
S
S&P/ASX 300
CMP
Over the past 12 months, CMP has underperformed S&P/ASX 300, delivering a return of -31% compared to S&P/ASX 300's 3% drop.
Stocks Performance
CMP vs S&P/ASX 300
Performance Gap
CMP vs S&P/ASX 300
Performance By Year
CMP vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Compumedics Ltd
Glance View
Compumedics makes medical devices and software used to monitor the brain, sleep, and breathing. Its main products include systems for sleep studies, neurological testing, and research recordings, along with the sensors, consumables, and analysis software that go with them. Hospitals, sleep clinics, researchers, and specialist doctors use these tools to diagnose conditions like sleep apnea and to study brain activity and other physiological signals. The company sells its equipment upfront and also earns recurring revenue from software, service, support, and consumable supplies. That mix matters because the installed base of devices often leads to follow-on sales of parts, upgrades, and maintenance. Its business sits in a niche part of healthcare where accurate signal measurement and reliable data handling are more important than flashy consumer branding. What makes Compumedics different is that it is not a broad hospital supplier; it is focused on highly specialized recording systems for sleep and neurodiagnostics. It sits between medical equipment makers and the clinicians who need precise test data, so its value comes from combining hardware, software, and domain-specific expertise into one system.